passage bio stock news

Find the latest news headlines from Passage Bio Inc. On average they anticipate Passage Bios stock price to reach 1700 in the next twelve months.

Passage Bio To Report First Quarter 2022 Financial Results On May 16 2022

Announced that the board of directors and Bruce Goldsmith PhD.

. NASDAQPASG Get Rating was the target of a large growth in short interest in May. A high-level overview of Passage Bio Inc. Passage Bio names new board chair following sudden death of Dr.

Their forecasts range from 600 to 3400. 1 day agoPosted by MarketBeat News on Jun 1st 2022. Is followed by the analysts listed above.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. 1 day agoPassage Bio which is focused on developing gene therapies for central nervous system disorders went public in 2020 raising 2488 million through its initial public stock. Passage Bio Inc.

Passage Bio to Report Fourth Quarter and Full-Year 2021 Financial Results on March 3 2022. Discover what drives us. Have mutually agreed that Dr.

Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not. Find the latest Passage Bio Inc. Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

The stock was purchased at an average price of 315 per. What are analysts forecasts for Passage Bio stock. PASG Complete Passage Bio Inc.

During the same quarter in the prior year the company posted 076 earnings per share. PASG stock price quote stock graph news analysis. PASG stock quote history news and other vital information to help you with your stock trading and investing.

Passage Bio Inc. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC. View real-time stock prices and stock quotes for a full financial overview.

Learn more about Passage Bio. Goldsmith bought 10000 shares of the stock in a transaction on Monday March 21st. This suggests a possible upside of.

Goldsmith will step down as president and a member of the. Passage Bio Stock Prediction. As a group analysts expect that Passage Bio will post -316 earnings per share for the.

The 13 analysts offering price forecasts for Passage Bio have a median target of 2462 with a high estimate of 4500 and a low estimate. Passage Bio owners buys 168300 shares worth 910K. Real time Passage Bio Inc.

Stock news by MarketWatch. 24 2022 GLOBE NEWSWIRE -- Passage Bio Inc. PASG Passage Bio Inc Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights Dosed first patient in Cohort 2 and completed dosing of Cohort 3 in.

1 day agoIn other news CEO Bruce A. As of May 15th there was.

Passage Bio Inc Investors And News Stock Information